Stay updated on Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial
Sign up to get notified when there's something new on the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page.

Latest updates to the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page
- Check5 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, signaling an internal patch to the study details page. No user-facing content changes are indicated by this update.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new Revision: v3.6.4 tag appears on the page, replacing the previous Revision: v3.6.3. This indicates an administrative update to the page’s versioning or content management.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.3, indicating a deployment of a newer version of the page template; no visible content changes are introduced.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded recruitment status No longer looking for participants and introduced new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study). Updated the Intervention/Treatment header formatting and revised the page revision from v3.5.5 to v3.6.0, removing the older revision label.SummaryDifference0.3%

- Check69 days agoChange DetectedThe page shows Revision: v3.5.5 replacing the previous v3.5.4 in the header, indicating a version update to the page. This update changes the metadata of the page but does not alter the study details or content.SummaryDifference0.0%

- Check90 days agoChange DetectedA new results posting entry dated 2026-05-12 was added for FORSYYN, including the Results Posted label and a detailed description of the study duration (30 weeks), phases (screening/run-in, randomization, treatment, follow-up), and the visit schedule and outcomes. Older 2024-era results-submission text and related eligibility/endpoints were removed.SummaryDifference6%

Stay in the know with updates to Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page.